Infosys stock price today: Shares of Infosys rose sharply on Friday, climbing over 5% on both the NSE and BSE after the IT major raised its FY26 constant-currency revenue growth guidance to 3–3.5% while maintaining its operating margin outlook at 20–22%. At 11 am, the stock was trading 5.04% or 80 points higher, reaching 1,679.65 on the BSE. On the NSE, Infosys gained 5.05%, also adding 80 points, to trade at 1,680.60. The stock followed a Q3 report showing a 2% year-on-year decline in consolidated net profit, which stood at Rs 6,654 crore compared with Rs 6,806 crore a year ago. Revenue from operations, however, grew 9% YoY to Rs 45,479 crore.At the same time, the company’s American Depository Receipts (ADRs) also climbed sharply, hitting an intraday peak of $19.45 before closing at $19.35, up 10.4% from Thursday’s $18.82. In total, ADRs have surged more than 7% over the past two sessions, ET reported.Here’s what investors should watch out for:Brokerages remained largely constructive on Infosys following the guidance upgrade, though views varied on near-term performance. Nomura maintained its Buy call on the stock with a target price of Rs 1,810, citing the company’s decision to raise its FY26 constant-currency revenue growth guidance from 2–3% to 3–3.5%. Elara Capital, meanwhile, retained its ‘Accumulate’ rating and increased its target price to Rs 1,770. The brokerage said Q3 revenue came in ahead of expectations, aided by the NHS deal, while margins were also better than anticipated. The brokerage cited strong performance in the first nine months of FY26 and healthy deal wins, which led to the IT giant revising its FY26 revenue growth guidance to 3–3.5%, up from the earlier 2–3% range. It added that to meet the revised outlook, Q4 growth would need to be between -1.7% and +0.2%, which it believes is achievable. The brokerage also flagged signs of recovery in discretionary spending within the BFSI segment, ET reported. Emkay Global also maintained its Buy rating with a target price of Rs 1,750, describing the third-quarter performance as mixed. While revenue exceeded estimates with 0.6% sequential growth in constant-currency terms, adjusted EBIT margin declined 20 basis points quarter-on-quarter to 20.8%. Emkay added that the revised guidance does not factor in potential revenue from the pending Telstra joint venture, reflecting caution at the lower end amid macro uncertainty, while a more optimistic scenario is built into the upper end. Earnings estimates for FY26–28 have been adjusted in the range of -2.1% to +0.5% to reflect the Q3 outcome.(Disclaimer: Recommendations and views on the stock market, other asset classes or personal finance management tips given by experts are their own. These opinions do not represent the views of The Times of India)